SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-000021
Filing Date
2024-01-03
Accepted
2024-01-03 07:06:50
Documents
15
Period of Report
2023-12-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20231230x8k.htm   iXBRL 8-K 41276
2 EX-10.1 pmn-20231230xex10d1.htm EX-10.1 20496
3 EX-99.1 pmn-20231230xex99d1.htm EX-99.1 13388
  Complete submission text file 0001558370-24-000021.txt   223522

Data Files

Seq Description Document Type Size
4 EX-101.SCH pmn-20231230.xsd EX-101.SCH 3954
5 EX-101.DEF pmn-20231230_def.xml EX-101.DEF 2874
6 EX-101.LAB pmn-20231230_lab.xml EX-101.LAB 18537
7 EX-101.PRE pmn-20231230_pre.xml EX-101.PRE 12280
9 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20231230x8k_htm.xml XML 5269
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 24504334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)